Speaking of SurgOnc artwork

The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cance

Speaking of SurgOnc

English - November 10, 2020 06:00 - 13 minutes - 15.7 MB - ★★★★★ - 6 ratings
Natural Sciences Science education globalcancersurgery research surgicaloncology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: The Landmark Series: Neuroendocrine Tumor Liver Metastases
Next Episode: Opioid Consumption Following Breast Surgery Decreases with a Brief Educational Intervention: A Randomized, Controlled Trial

Rick Green, MD and Dr. Anna Weiss, MD discuss clinical trials that have defined the role of neoadjuvant endocrine therapy in patients with estrogen receptor-positive breast cancer. Dr. Weiss is author of “The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer.”

Dr. Weiss is Assistant Professor of Surgery at Harvard Medical School, Boston, MA.